ProCE Banner Activity

Importance of Naloxone Coprescription in High-Risk Patients Receiving Opioids

Clinical Thought

All patients prescribed opioids should be educated on naloxone and offered a coprescription, but there are barriers to its widespread use. Thus, efforts on coprescribing naloxone may need to be targeted to patients at the highest risk for overdose. This expert commentary provides information on identifying such patients.

Released: July 21, 2023

Share

Faculty

Mitchell Crouch

Mitchell Crouch, PharmD

Clinical Pharmacy Specialist in Psychiatry
The Harris Center for Mental Health and IDD
Houston, Texas

Provided by

Provided by Clinical Care Options, LLC, and in partnership with the American Academy of Physical Medicine and Rehabilitation, Alliance to Advance Comprehensive Integrative Pain Management, Practicing Clinicians Exchange, and ProCE.

ProCE Banner

Supporters

This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see this link for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the FDA.

Opioid Analgesic REMS Program Companies

Partners

Alliance to Advance Comprehensive Integrative Pain Management

ProCE Banner

American Academy of Physical Medicine and Rehabilitation

ProCE Banner

Practicing Clinicians Exchange

ProCE Banner

ProCE

ProCE Banner

Disclosure

Primary Author

Mitchell Crouch, PharmD

Clinical Pharmacy Specialist in Psychiatry
The Harris Center for Mental Health and IDD
Houston, Texas

Mitchell Crouch, PharmD, has no relevant financial relationships to disclose.